ATLAS trial investigator Guy Young, MD, Children's Hospital Los Angeles and University of Southern California Keck School of ...

Children treated with mepolizumab during asthma flare-ups showed a significant reduction in eosinophil-driven type 2 (T2) ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog. This rapid-acting insulin ...

We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.

There is a test that is usually carried out to find out whether a child has tuberculosis or not, namely the Mantoux test. The ...

In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite contro ...

That silence around Type 1 diabetes is exactly what advocates and educators hope to change. In a move toward inclusivity and awareness, a new Barbie doll has been released, Barbie with Type 1 diabetes ...

Panelists discuss how switching from intravenous (IV) to subcutaneous (SubQ) therapies requires proactive management of reimbursement, authorizations, and clinical workflows—emphasizing early payer ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...